NCT03223428 2024-07-24
RELAX
TerSera Therapeutics LLC
Completed
Clinical Trials
5 trialsNCT04543955 2023-06-27
Telotristat With Lutathera in Neuroendocrine Tumors
University of Kentucky
Phase 2 Terminated
NCT04713202 2023-02-10
NET-PACS
Big Ten Cancer Research Consortium
Phase 2 Withdrawn
NCT04672876 2021-12-17
Telotristat Ethyl for Reducing Intraoperative Carcinoid Crisis in Patients With Neuroendocrine Tumors
University of Chicago
Phase 2 Withdrawn
NCT04034745 2020-12-30
Open Label Study to Analyze the Effect of Telotristat Ethyl on Weight Regulation/Gain
Cedars-Sinai Medical Center
Withdrawn